Skip to main content

Brazilian Outlook

Abbvie Shares Fall as Wall Street Focuses on Filler Weakness




The Botox maker’s 2026 profit forecast surpassed Wall Street’s expectations, though investors saw vulnerabilities in the company’s filler brand Juvéderm.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *